Patents by Inventor Phillip Moheno

Phillip Moheno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CALCIUM FOLATE (CAFOLATE) AND THERAPEUTIC METHODS BASED THEREON
    Publication number: 20170143720
    Abstract: Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the administration of CaFolate. In one embodiment is a method of treating cancer comprising administration of CaFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of CaFolate.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 25, 2017
    Inventor: Phillip Moheno
  • CALCIUM FOLATE (CAFOLATE) AND THERAPEUTIC METHODS BASED THEREON
    Publication number: 20150010509
    Abstract: Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the administration of CaFolate. In one embodiment is a method of treating cancer comprising administration of CaFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of CaFolate.
    Type: Application
    Filed: January 29, 2013
    Publication date: January 8, 2015
    Applicant: SanRx Pharmaceuticals, Inc.
    Inventor: Phillip Moheno
  • PTERIN BASED THERAPIES FOR INFLAMMATORY CONDITIONS
    Publication number: 20120251495
    Abstract: Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection based upon the administration of calcium pterin. In one embodiment is a method of treating cancer comprising administration of dipterinyl calcium pentahydrate (DCP). In another embodiment is a method of treating hepatitis B virus infection comprising administration of dipterinyl calcium pentahydrate (DCP).
    Type: Application
    Filed: January 16, 2009
    Publication date: October 4, 2012
    Inventors: Phillip Moheno, Wolfgang Pfleiderer, Antonio DiPasquale, Arnold Rheingold, Dietmar Fuchs
  • Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon
    Publication number: 20100105692
    Abstract: Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.
    Type: Application
    Filed: December 21, 2009
    Publication date: April 29, 2010
    Inventors: Phillip Moheno, Wolfgang Pfleiderer
  • Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
    Patent number: 7662820
    Abstract: Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 16, 2010
    Assignee: SanRX Pharmaceuticals, Inc.
    Inventors: Phillip Moheno, Wolfgang Pfleiderer
  • Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
    Publication number: 20080166355
    Abstract: Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 10, 2008
    Applicant: SanRx Pharmaceuticals, Inc.
    Inventors: Phillip Moheno, Wolfgang Pfleiderer